Published in Obes Surg on April 01, 2005
Effect of Roux-en-Y Gastric Bypass or Gastric Sleeve Surgery on Type 2 Diabetes | NCT02713555
The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery. Diabetes Care (2010) 2.64
Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats. Gastroenterology (2011) 2.45
Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. Gastroenterology (2009) 2.19
Duodenal nutrient exclusion improves metabolic syndrome and stimulates villus hyperplasia. Gut (2013) 2.18
Improved heart rate recovery after marked weight loss induced by gastric bypass surgery: two-year follow up in the Utah Obesity Study. Heart Rhythm (2010) 2.06
Ileal interposition surgery improves glucose and lipid metabolism and delays diabetes onset in the UCD-T2DM rat. Gastroenterology (2010) 1.96
All bariatric surgeries are not created equal: insights from mechanistic comparisons. Endocr Rev (2012) 1.74
Meal-induced hormone responses in a rat model of Roux-en-Y gastric bypass surgery. Endocrinology (2010) 1.64
GLP-1R responsiveness predicts individual gastric bypass efficacy on glucose tolerance in rats. Diabetes (2013) 1.58
Do Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence? Obes Surg (2008) 1.45
Metabolic syndrome and the hepatorenal reflex. Surg Neurol Int (2016) 1.40
Roles of increased glycemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypass. Eur J Endocrinol (2017) 1.39
Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus. Nat Rev Endocrinol (2010) 1.37
Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35. Surg Endosc (2008) 1.35
Effects of bariatric surgery on glucose homeostasis and type 2 diabetes. Gastroenterology (2012) 1.33
Impact of Roux-en-Y gastric bypass surgery on rat intestinal glucose transport. Am J Physiol Gastrointest Liver Physiol (2009) 1.24
Hepatic and peripheral insulin sensitivity and diabetes remission at 1 month after Roux-en-Y gastric bypass surgery in patients randomized to omentectomy. Diabetes Care (2011) 1.21
Weight-independent effects of roux-en-Y gastric bypass on glucose homeostasis via melanocortin-4 receptors in mice and humans. Gastroenterology (2012) 1.19
Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease. Cardiovasc Diabetol (2010) 1.07
The Gordian Knot of dysbiosis, obesity and NAFLD. Nat Rev Gastroenterol Hepatol (2013) 1.06
The great debate: medicine or surgery: what is best for the patient with type 2 diabetes? Diabetes Care (2011) 1.06
Bypassing the duodenum does not improve insulin resistance associated with diet-induced obesity in rodents. Obesity (Silver Spring) (2010) 1.02
GLP-1 plays a limited role in improved glycemia shortly after Roux-en-Y gastric bypass: a comparison with intensive lifestyle modification. Diabetes (2014) 0.97
Obesity surgery and gut-brain communication. Physiol Behav (2011) 0.97
Dissociation of intestinal and hepatic activities of FXR and LXRα supports metabolic effects of terminal ileum interposition in rodents. Diabetes (2013) 0.97
Role of Gut-Related Peptides and Other Hormones in the Amelioration of Type 2 Diabetes after Roux-en-Y Gastric Bypass Surgery. ISRN Endocrinol (2012) 0.94
A gut feeling to cure diabetes: potential mechanisms of diabetes remission after bariatric surgery. Diabetes Metab J (2014) 0.94
Can Roux-en-Y gastric bypass provide a lifelong solution for diabetes mellitus? Can J Surg (2009) 0.93
PYY3-36 and oxyntomodulin can be additive in their effect on food intake in overweight and obese humans. Diabetes (2010) 0.92
Long-term weight-loss in gastric bypass patients carrying melanocortin 4 receptor variants. PLoS One (2014) 0.89
The mechanisms of surgical treatment of type 2 diabetes. Obes Surg (2005) 0.89
Rapid improvement in diabetes after gastric bypass surgery: is it the diet or surgery? Diabetes Care (2013) 0.87
Mechanisms underlying weight loss and metabolic improvements in rodent models of bariatric surgery. Diabetologia (2014) 0.87
Obesity and diabetes: the impact of bariatric surgery on type-2 diabetes. World J Surg (2009) 0.87
Mechanism of metabolic advantages after bariatric surgery: it's all gastrointestinal factors versus it's all food restriction. Diabetes Care (2013) 0.87
Does the length of the biliary limb influence medium-term laboratory remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass in morbidly obese patients? Wideochir Inne Tech Maloinwazyjne (2014) 0.86
Activation of natriuretic peptides and the sympathetic nervous system following Roux-en-Y gastric bypass is associated with gonadal adipose tissues browning. Mol Metab (2015) 0.86
Longitudinal assessment of food intake, fecal energy loss, and energy expenditure after Roux-en-Y gastric bypass surgery in high-fat-fed obese rats. Obes Surg (2013) 0.85
The sum of many parts: potential mechanisms for improvement in glucose homeostasis after bariatric surgery. Curr Diab Rep (2014) 0.85
Isolated duodenal exclusion increases energy expenditure and improves glucose homeostasis in diet-induced obese rats. Am J Physiol Regul Integr Comp Physiol (2012) 0.83
Obesity-related cardiorenal disease: the benefits of bariatric surgery. Nat Rev Nephrol (2013) 0.83
Overview of emerging concepts in metabolic surgery. Perm J (2010) 0.83
Mechanisms behind the immediate effects of Roux-en-Y gastric bypass surgery on type 2 diabetes. Theor Biol Med Model (2013) 0.83
Bariatric surgery for severe obesity in two adolescents with type 1 diabetes. Pediatrics (2013) 0.81
Surgical models of Roux-en-Y gastric bypass surgery and sleeve gastrectomy in rats and mice. Nat Protoc (2015) 0.81
Six and 12 Weeks of Caloric Restriction Increases β Cell Function and Lowers Fasting and Postprandial Glucose Concentrations in People with Type 2 Diabetes. J Nutr (2015) 0.80
Reduction of 8-iso-prostaglandin F2α in the first week after Roux-en-Y gastric bypass surgery. Obesity (Silver Spring) (2011) 0.79
Tissue-specific effects of bariatric surgery including mitochondrial function. J Obes (2011) 0.79
Lower fetuin-A, retinol binding protein 4 and several metabolites after gastric bypass compared to sleeve gastrectomy in patients with type 2 diabetes. PLoS One (2014) 0.78
Long-term diabetic response to gastric bypass. J Surg Res (2014) 0.78
Aberrant liver insulin receptor isoform a expression normalises with remission of type 2 diabetes after gastric bypass surgery. PLoS One (2015) 0.77
Plasma amino acid and metabolite signatures tracking diabetes progression in the UCD-T2DM rat model. Am J Physiol Endocrinol Metab (2016) 0.77
Effect of gastrointestinal surgical manipulation on metabolic syndrome: a focus on metabolic surgery. Gastroenterol Res Pract (2012) 0.77
Changes in erythrocyte sedimentation rate, white blood cell count, liver enzymes, and magnesium after gastric bypass surgery. J Obes (2011) 0.77
Does caloric restriction alone explain the effects of Roux-en-Y gastric bypass on glucose metabolism? Not by a long limb. Diabetes (2013) 0.77
GLP-1R agonism enhances adjustable gastric banding in diet-induced obese rats. Diabetes (2013) 0.77
Liver ENPP1 protein increases with remission of type 2 diabetes after gastric bypass surgery. BMC Gastroenterol (2014) 0.77
Enteroendocrine secretion after Roux-en-Y gastric bypass: is it important? Neurogastroenterol Motil (2013) 0.77
The oral microflora in obesity and type-2 diabetes. J Oral Microbiol (2012) 0.77
Roux-en-Y Gastric Bypass Acutely Decreases Protein Carbonylation and Increases Expression of Mitochondrial Biogenesis Genes in Subcutaneous Adipose Tissue. Obes Surg (2015) 0.76
Development of minimally invasive techniques for management of medically-complicated obesity. World J Gastroenterol (2014) 0.76
Improved glucose metabolism following bariatric surgery is associated with increased circulating bile acid concentrations and remodeling of the gut microbiome. World J Gastroenterol (2016) 0.76
Contribution of the distal small intestine to metabolic improvement after bariatric/metabolic surgery: Lessons from ileal transposition surgery. J Diabetes Investig (2016) 0.75
Bariatric Surgery Prior to Index Screening Colonoscopy Is Associated With a Decreased Rate of Colorectal Adenomas in Obese Individuals. Clin Transl Gastroenterol (2017) 0.75
Recent advances in metabolic and bariatric surgery. F1000Res (2016) 0.75
Bariatric surgery in morbidly obese insulin resistant humans normalises insulin signalling but not insulin-stimulated glucose disposal. PLoS One (2015) 0.75
Metabolic syndrome and the hepatorenal reflex. Surg Neurol Int (2016) 0.75
Bariatric surgery and type 2 diabetes mellitus: surgically induced remission. J Diabetes Sci Technol (2008) 0.75
Network identification of hormonal regulation. PLoS One (2014) 0.75
Is type 2 diabetes a surgical disease? Can J Surg (2007) 0.75
β-cell function after weight-loss induced by bariatric surgery. Physiology (Bethesda) (2014) 0.75
Identification of Novel Changes in Human Skeletal Muscle Proteome After Roux-en-Y Gastric Bypass Surgery. Diabetes (2016) 0.75
Effects of sleeve gastrectomy on insulin resistance. Clujul Med (2016) 0.75
Bariatric Surgery for Adolescents with Type 2 Diabetes: an Emerging Therapeutic Strategy. Curr Diab Rep (2017) 0.75
Roux-en-Y gastric bypass surgery suppresses hypothalamic PTP1B protein level and alleviates leptin resistance in obese rats. Exp Ther Med (2017) 0.75
Metabolic Surgery in Korea: What to Consider before Surgery. Endocrinol Metab (Seoul) (2017) 0.75
An analysis of DNA methylation in human adipose tissue reveals differential modification of obesity genes before and after gastric bypass and weight loss. Genome Biol (2015) 1.19
Long-term outcomes after gastric bypass. Obes Surg (2005) 1.18
Risk of dissemination with biopsy of colorectal liver metastases. Dis Colon Rectum (2003) 1.17
Relationship of 99mtechnetium labelled macroaggregated albumin (99mTc-MAA) uptake by colorectal liver metastases to response following Selective Internal Radiation Therapy (SIRT). BMC Nucl Med (2005) 1.06
Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level. BMC Cancer (2008) 1.03
Self-reported diabetes and health behaviors in remote indigenous communities in northern queensland, australia. Diabetes Care (2003) 0.87
Proteomic analysis of advanced colorectal cancer by laser capture microdissection and two-dimensional difference gel electrophoresis. J Proteomics (2011) 0.87
Selective internal radiation therapy for gastrointestinal neuroendocrine tumour liver metastases: a new and effective modality for treatment. Int J Hepatol (2011) 0.84
Human resources for health: lessons from the cholera outbreak in Papua New Guinea. Western Pac Surveill Response J (2013) 0.81
Overexpression of aminoacylase 1 is associated with colorectal cancer progression. Hum Pathol (2013) 0.78
Insulin receptor-insulin interaction kinetics using multiplex surface plasmon resonance. J Mol Recognit (2013) 0.76
Portal hypertension and liver surgery following selective internal radiation therapy with 90Yttrium microspheres. J Clin Oncol (2006) 0.76
Tasmania: green pastures for the Browne family of pharmacists. Pharm Hist Aust (2002) 0.75
A tale of forgery, pharmacy and a famous murder. Pharm Hist Aust (2003) 0.75
Teaching pharmacy history: the antipodean experience. Pharm Hist Aust (2002) 0.75
Door to door collectibles. Salves, lotions, pills and potions from W.T. Rawleigh. Pharm Hist Aust (2002) 0.75
The impact of an international faculty development program on simulation-based healthcare education. Med Teach (2012) 0.75